Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 6-fluoro-2-(4-(pyridin-2-yl)but-3-yn-1-yl)imidazo(1,2-a)pyridine
1. 872363-17-2
2. Adx48621
3. Dipraglurant [inn]
4. Adx-48621
5. Cv8jzr21a1
6. Chembl2346738
7. 6-fluoro-2-[4-(pyridin-2-yl)-3-butynyl]imidazo[1,2-a]pyridine
8. 6-fluoro-2-(4-(pyridin-2-yl)but-3-yn-1-yl)imidazo(1,2-a)pyridine
9. 6-fluoro-2-(4-pyridin-2-ylbut-3-ynyl)imidazo[1,2-a]pyridine
10. 6-fluoro-2-[4-(2-pyridinyl)-3-butyn-1-yl]imidazo[1,2-a]pyridine
11. Unii-cv8jzr21a1
12. 6-fluoro-2-(4-(pyridin-2-yl)but-3-yn-1-yl)imidazo[1,2-a]pyridine
13. Schembl103033
14. Gtpl6452
15. Dtxsid90236230
16. Bcp23706
17. 6-fluoro-2-[4-(2-pyridinyl)-3-butyn-1-yl]-imidazo[1,2-a]pyridine
18. Bdbm50431705
19. Zinc72266314
20. Cs-0690
21. Db12733
22. Sb16993
23. Ncgc00351745-02
24. Hy-14859
25. Db-076892
26. Ft-0705373
27. J3.560.334d
28. A916694
29. Adx 48621;adx48621;adx-48621
30. Q19596938
31. 2-(4-{6-fluoroimidazo[1,2-a]pyridin-2-yl}but-1-yn-1-yl)pyridine
| Molecular Weight | 265.28 g/mol |
|---|---|
| Molecular Formula | C16H12FN3 |
| XLogP3 | 3.5 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 3 |
| Exact Mass | 265.10152556 g/mol |
| Monoisotopic Mass | 265.10152556 g/mol |
| Topological Polar Surface Area | 30.2 Ų |
| Heavy Atom Count | 20 |
| Formal Charge | 0 |
| Complexity | 386 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Dipraglurant manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dipraglurant, including repackagers and relabelers. The FDA regulates Dipraglurant manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dipraglurant API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Dipraglurant supplier is an individual or a company that provides Dipraglurant active pharmaceutical ingredient (API) or Dipraglurant finished formulations upon request. The Dipraglurant suppliers may include Dipraglurant API manufacturers, exporters, distributors and traders.
Dipraglurant Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dipraglurant GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dipraglurant GMP manufacturer or Dipraglurant GMP API supplier for your needs.
A Dipraglurant CoA (Certificate of Analysis) is a formal document that attests to Dipraglurant's compliance with Dipraglurant specifications and serves as a tool for batch-level quality control.
Dipraglurant CoA mostly includes findings from lab analyses of a specific batch. For each Dipraglurant CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dipraglurant may be tested according to a variety of international standards, such as European Pharmacopoeia (Dipraglurant EP), Dipraglurant JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dipraglurant USP).
LOOKING FOR A SUPPLIER?
